India’s plastic surgery market is expanding, making the country a global hub for aesthetic procedures. It ranks second in rhinoplasty (nose reshaping) and third in liposuction, demonstrating the growing demand for surgical enhancements. Overall, India holds the seventh position worldwide for both surgical and non-surgical aesthetic procedures. Market projections The plastic surgery market is growing at an unprecedented pace. A ...
Eighteen-year-old Lalit Patidar from Madhya Pradesh set the Guinness World Record for the world’s hairiest face on a man. He achieved this record due to hypertrichosis, a rare condition also called werewolf syndrome, which he has had since birth. Despite facing societal challenges, Lalit has embraced his unique appearance and now holds a prestigious place in the record books. A ...
Galderma Group AG announced its financial results for 2024, showcasing strong growth across all business segments. The company reported a net sales increase of 12.3% on a constant currency basis, reaching $2.72 billion. The continued expansion of its injectable aesthetics and dermatological skincare divisions drove this growth. Key financial highlights Core EBITDA surged by 26.6% to $651 million. The core ...
Alkem Laboratories Ltd expands its presence in high-growth therapeutic areas with the acquisition of Adroit Biomed and Bombay Ortho Industries. These acquisitions will enhance Alkem’s dermatology and cosmetology portfolio while expanding its footprint in the medical device sector. Adroit Biomed acquisition The company will acquire Adroit Biomed, a company specialising in dermatology and cosmetology, for Rs 140 crore in two ...
Galderma showcased significant updates across its dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting. The company reinforces its leadership commitment in dermatology innovation with 22 scientific presentations, including two oral e-posters. Nemluvio Nemolizumab (Nemulizumab), Galderma’s treatment for prurigo nodularis and atopic dermatitis, was a key focus at AAD 2025. A new oral presentation showcases Nemluvio’s efficacy ...
Laser hair removal (LHR) for private part areas has evolved into a sought-after treatment in dermatology and aesthetic medicine. With growing patient awareness and demand for long-term hair reduction, practitioners must stay ahead by offering effective and advanced solutions. Patients are increasingly opting for LHR over traditional methods such as shaving, waxing, or depilatory creams. Conventional methods cause irritation, ingrown ...
Aesthetic medicine in India is growing at an unprecedented rate offering significant opportunities for doctors, professionals, and industry stakeholders. The growing demand for aesthetic operations, new technologies, and beauty enhancement procedures drives the growth of this industry. Foreign and domestic enterprises expanding their consumer base, along with competition, business growth, and investment, also drive the growth of this industry. The ...
Have you heard of beef tallow in skincare? In the world of beauty, people are constantly experimenting with new and unique ingredients to achieve glowing, radiant skin. One trend that’s recently gained attention is the use of beef tallow, which is actually a rendered beef fat. It is now used as a natural alternative to moisturisers and creams. While it ...
Have you noticed how spontaneously the new aesthetic industry trends are evolving? As new industry trends emerge on a frequent basis, patients’ approaches towards aesthetic treatments are evolving. With technology advancing and expectations rising, there are a few trends that are making their mark and are here to stay. From personalised treatments to faster recovery solutions, these trends are shaping ...
Dr Mir Shahnawaz, founder of DERMIS, recently discussed advances in treating atopic dermatitis at the RAD Symposium in Jaipur. India’s top dermatologists attended the event, which focused on groundbreaking developments in skin health and innovative treatments. A key highlight was the discussion on Abrocitinib, a JAK1 inhibitor, which has shown promising results for treating moderate to severe atopic dermatitis. Atopic ...